Post-marketing safety surveillance of vortioxetine hydrobromide: a pharmacovigilance study leveraging FAERS database
This study identified adverse events (AEs) associated with vortioxetine. Our findings offer valuable insights for optimizing the use of vortioxetine hydrobromide and reducing potential side effects, serving as a reference for its rational and safe clinical application.
Authors
- Ying Zhang (ORCID: https://orcid.org/0000-0003-4363-5666)
- Yaogui Ning (ORCID: https://orcid.org/0000-0002-6394-9032)
- Shengzhu Sun
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2025-02-24
- DOI
- https://doi.org/10.3389/fpsyt.2025.1532803
- Citations
- 1
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 1.39